CClinicalTrials.gg
CompletedNCT05694442Updated May 11, 2023

The Effect of Lipmatte K

An interventional study of Lipmatte K in Aesthetic, Cosmetic and Healthy, sponsored by Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre. Completed at 1 site in Malaysia. Open to female participants aged 30 Years to 55 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-05-11.

Sponsored by Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre · Not applicable, Interventional, and Other

From the registry’s dates

  • Registered 4 months after the study started (first participant enrolled Sep 2022, registered Jan 2023).
Phase
Not applicable
Study type
Interventional
Enrollment
34
Allocation
Not applicable
Ages
30 Years to 55 Years
Sex
Female
01

Study summary

This study is conducted to evaluate the safety and the effectiveness of Lipmatte K on lip hydration and brightening. The study duration is 4 weeks and the lip assessment will be carried out at baseline, week 2 and week 4.The main questions this study aims to answer are:

  1. The hydration effect of the product on lip.
  2. The brightening effect of the product on lip.
  3. To observe any adverse effect occurrence with the usage of the product.
02

Conditions studied

  • Aesthetic
  • Cosmetic
  • Healthy
03

In context

Lead sponsor

Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre is the lead sponsor of 7 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
30 Years to 55 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Inclusion criteria

  • Malaysia citizen
  • Female (age 30-55 years old)
  • Lip with mild-to-moderate dryness

Exclusion criteria

Exclusion Criteria:

  • Subjects who have history of performing lips-related treatments such as lip augmentation (filler, botox, laser)
  • Heavy lips desquamation or chapped lip conditions
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
34 participants (actual)

Study arms

  • Experimental
    Lipmatte K

    Participants will used Lipmatte K everyday for 4 weeks

    Other: Lipmatte K

Interventions

  • OtherLipmatte K

    Lipmatte K contain ingredients that may hydrate and brighten the lip

06

What researchers measure

Primary outcomes

  1. Change in lip roughness from baseline and at week 2 and 4 after using Lipmatte K

    Degree of lip roughness for each participant's will be determined by dermatologist based on score 0 to 2 (0= no desquamations, 1 = slight desquamations and 2 = heavy desquamations)

    Time frame: Baseline, Week 2, Week 4

  2. Change in lip wrinkles from baseline and at week 2 and 4 after using Lipmatte K

    Degree of lip wrinkle for each participant's will be determined by dermatologist based on score 0- 2 (0 = no/almost no vertical wrinkles, 1 = no deep vertical wrinkles and 2 = many deep vertical wrinkles)

    Time frame: Baseline, Week 2, Week 4

  3. Visual assessment of the lip from baseline and at week 2 and 4 after using Lipmatte K

    Image of the lip will be captured using digital camera (Nikon D5100) to observed the brightening effect of the lipmatte

    Time frame: Baseline, Week 2, Week 4

  4. Adverse effect after using Lipmatte K

    Based on adverse effect occurrence on participants that occur during study period (4 weeks)

    Time frame: Week 4

07

Study locations

1 site
  • Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
    Petaling Jaya, Selangor 47810, Malaysia
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05694442
Lead sponsor
Ungku Shahrin Medical Aesthetic Research & Innovation (USMARI) Centre
Responsible party
Sponsor
First posted
Jan 23, 2023
Start date
Sep 1, 2022
Primary completion
Dec 31, 2022
Completion
Mar 1, 2023
Last update
May 11, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion